355 related articles for article (PubMed ID: 35711458)
1. IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells.
Poto R; Quinti I; Marone G; Taglialatela M; de Paulis A; Casolaro V; Varricchi G
Front Immunol; 2022; 13():880412. PubMed ID: 35711458
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells.
Poto R; Patella V; Criscuolo G; Marone G; Coscioni E; Varricchi G
Clin Exp Med; 2023 Aug; 23(4):1265-1276. PubMed ID: 35879625
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
[TBL] [Abstract][Full Text] [Related]
4. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.
Patella V; Bouvet JP; Marone G
J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815
[TBL] [Abstract][Full Text] [Related]
5. Basophil mediator release in atopic dermatitis.
Bull HA; Courtney PF; Bunker CB; Rustin MH; Pearce FL; Dowd PM
J Invest Dermatol; 1993 Mar; 100(3):305-9. PubMed ID: 7680056
[TBL] [Abstract][Full Text] [Related]
6. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells.
Marone G; Casolaro V; Paganelli R; Quinti I
J Invest Dermatol; 1989 Aug; 93(2):246-52. PubMed ID: 2787823
[TBL] [Abstract][Full Text] [Related]
7. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis.
Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M
Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875
[TBL] [Abstract][Full Text] [Related]
8. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
9. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.
Patella V; Casolaro V; Björck L; Marone G
J Immunol; 1990 Nov; 145(9):3054-61. PubMed ID: 1698870
[TBL] [Abstract][Full Text] [Related]
10. Secretion of cytokines, histamine and leukotrienes in chronic urticaria.
Ferrer M; Luquin E; Sanchez-Ibarrola A; Moreno C; Sanz ML; Kaplan AP
Int Arch Allergy Immunol; 2002 Nov; 129(3):254-60. PubMed ID: 12444324
[TBL] [Abstract][Full Text] [Related]
11. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue.
Genovese A; Stellato C; Patella V; Lamparter-Schummert B; de Crescenzo G; Adt M; Marone G
Int J Clin Lab Res; 1996; 26(3):192-8. PubMed ID: 8905451
[TBL] [Abstract][Full Text] [Related]
12. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
[TBL] [Abstract][Full Text] [Related]
13. A human monoclonal IgE antibody that binds to MGL_1304, a major allergen in human sweat, without activation of mast cells and basophils.
Ishii K; Hiragun M; Hiragun T; Kan T; Kawaguchi T; Yanase Y; Tanaka A; Takahagi S; Hide M
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):99-104. PubMed ID: 26541454
[TBL] [Abstract][Full Text] [Related]
14. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.
Niimi N; Francis DM; Kermani F; O'Donnell BF; Hide M; Kobza-Black A; Winkelmann RK; Greaves MW; Barr RM
J Invest Dermatol; 1996 May; 106(5):1001-6. PubMed ID: 8618029
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses.
Wagner B; Miller WH; Erb HN; Lunn DP; Antczak DF
Vet Immunol Immunopathol; 2009 Nov; 132(1):53-61. PubMed ID: 19836083
[TBL] [Abstract][Full Text] [Related]
16. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils.
Borrelli I; Loffredo S; Staiano RI; Frattini A; Marone G; Triggiani M
Int J Immunopathol Pharmacol; 2010; 23(3):737-44. PubMed ID: 20943043
[TBL] [Abstract][Full Text] [Related]
17. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma.
Bischoff SC; Zwahlen R; Stucki M; Müllner G; de Weck AL; Stadler BM; Dahinden CA
Int Arch Allergy Immunol; 1996 Jul; 110(3):261-71. PubMed ID: 8688673
[TBL] [Abstract][Full Text] [Related]
18. Histamine releasability of basophils and skin mast cells in chronic urticaria.
Zuberbier T; Schwarz S; Hartmann K; Pfrommer C; Czarnetzki BM
Allergy; 1996 Jan; 51(1):24-8. PubMed ID: 8721524
[TBL] [Abstract][Full Text] [Related]
19. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
20. Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release.
Stellato C; de Crescenzo G; Patella V; Mastronardi P; Mazzarella B; Marone G
J Allergy Clin Immunol; 1996 Mar; 97(3):838-50. PubMed ID: 8613641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
